JP2022501371A5 - - Google Patents

Info

Publication number
JP2022501371A5
JP2022501371A5 JP2021515509A JP2021515509A JP2022501371A5 JP 2022501371 A5 JP2022501371 A5 JP 2022501371A5 JP 2021515509 A JP2021515509 A JP 2021515509A JP 2021515509 A JP2021515509 A JP 2021515509A JP 2022501371 A5 JP2022501371 A5 JP 2022501371A5
Authority
JP
Japan
Prior art keywords
optionally substituted
ester
sitosterol
alkylc2
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021515509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022501371A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/051940 external-priority patent/WO2020061317A1/en
Publication of JP2022501371A publication Critical patent/JP2022501371A/ja
Publication of JP2022501371A5 publication Critical patent/JP2022501371A5/ja
Ceased legal-status Critical Current

Links

JP2021515509A 2018-09-19 2019-09-19 ステロールの精製 Ceased JP2022501371A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862733522P 2018-09-19 2018-09-19
US62/733,522 2018-09-19
PCT/US2019/051940 WO2020061317A1 (en) 2018-09-19 2019-09-19 Sterol purification

Publications (2)

Publication Number Publication Date
JP2022501371A JP2022501371A (ja) 2022-01-06
JP2022501371A5 true JP2022501371A5 (enExample) 2022-09-13

Family

ID=69888799

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021515509A Ceased JP2022501371A (ja) 2018-09-19 2019-09-19 ステロールの精製

Country Status (6)

Country Link
US (1) US20210347810A1 (enExample)
EP (1) EP3852765A4 (enExample)
JP (1) JP2022501371A (enExample)
CA (1) CA3112878A1 (enExample)
MA (1) MA53666A (enExample)
WO (1) WO2020061317A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115684404B (zh) * 2022-10-27 2024-12-13 广东省科学院动物研究所 一种冬虫夏草的指纹图谱构建方法及应用
EP4694871A1 (en) * 2023-04-14 2026-02-18 Beijing Jitai Pharmaceutical Technology Co., Ltd. Lipid nanoparticle compositions and uses thereof
MA62195B1 (fr) * 2023-09-01 2025-07-31 École Supérieure Des Industries Du Textile Et De L'habillement (Esith) Composition ayant une activité antitumoral obtenues à partir de dérivés de molécules d’extrait de la plante d’alfa
WO2026029597A1 (ko) * 2024-07-31 2026-02-05 주식회사 메디치바이오 신규한 스테롤 지질 또는 이의 유도체를 함유하는 지질 나노입자 조성물
EP4700037A1 (en) * 2024-08-20 2026-02-25 Otto-von-Guericke-Universität Magdeburg Körperschaft des Öffentlichen Rechts Synthesis of isotope labeled cholesterol derivatives as diagnostic agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1002346A (en) * 1963-10-10 1965-08-25 Searle & Co Aminoalkyl esters of 3ª‰-hydroxypregn-5-en-20-one
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
AU2946600A (en) * 1999-03-04 2000-09-21 Eugene Science Inc. Water-soluble sterol derivative for inhibiting cholesterol absorption and process for preparing the same
CA2762095A1 (en) * 2009-05-16 2010-11-25 Kunyuan Cui Compositions comprising cationic amphiphiles and colipids for delivering therapeutic molecules
SI2506857T1 (en) * 2009-12-01 2018-08-31 Translate Bio, Inc. Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
CN102978272B (zh) * 2011-09-06 2014-10-15 江南大学 一种植物甾烷醇衍生物的制备方法
WO2013076257A1 (en) * 2011-11-24 2013-05-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Process for the preparation of sterol derivatives
FR3024361B1 (fr) * 2014-07-30 2017-11-24 Affichem Utilisation de derives de sterols pour traitement de la perte auditive neurosensorielle et composition correspondante
CN104402960B (zh) * 2014-12-16 2016-01-13 吉林农业大学 糠酸环戊烷并多氢菲酯a及其提取方法和药物用途
KR101796822B1 (ko) * 2015-02-12 2017-11-10 계명대학교 산학협력단 나노 운반체 및 이를 함유하는 피부 외용제 조성물
US20170325457A1 (en) * 2016-04-28 2017-11-16 Preceres Inc. Formulations for the delivery of active agents to insects, plants, and plant pathogens
CN106987024B (zh) * 2017-04-13 2019-02-05 东南大学 一种红外兼容微波纳米复合吸波材料及其制备方法

Similar Documents

Publication Publication Date Title
CN100360550C (zh) 肝脏x受体激动剂
JP6693859B2 (ja) プロスタグランジンアミドの新規製造方法
WO2009089076A4 (en) Processes for the preparation and purification of paliperidone palmitate
JP2014503001A5 (enExample)
TWI687396B (zh) N-[4-(1-胺基乙基)苯基]磺醯胺衍生物掌性解析之方法
JP2012531453A (ja) S−[2−[1−(2−エチルブチル)シクロヘキシルカルボニルアミノ]−フェニル]−2−メチルチオプロピオナートの製造及び結晶化
JPWO2019044266A1 (ja) ピラゾール−4−カルボキサミド誘導体の製造方法
TW201100386A (en) Processes for treating substituted pyrazoles
EP2221313A1 (en) Process for the preparation of ursodeoxycholic acid disodium 3,7-disulfate
CN102964414A (zh) 17位甾体羧酸酯的合成方法
CN104945415B (zh) 7H‑苯并异噁唑并[7,6‑e][1,3]噁嗪类衍生物及应用
JP5731397B2 (ja) 3,5−セコ−4−ノル−コレスタンの新規オキシム誘導体、それを含む医薬組成物、及びその調製方法
BE897000A (fr) Nouveaux derives de la 1,4-dihydropyridine,leur preparation et leur utilisation comme medicaments
CN102898357A (zh) 用于制备依托考昔的中间体1-(6-甲基吡啶-3-基)-2-[4-(甲磺酰基)苯基]乙酮的新方法
JPH0873404A (ja) ホスホリパーゼa2阻害活性を有する新規カルボン酸誘導体
JP5157154B2 (ja) 4’−(アルコキシカルボニル)ビシクロヘキシル−4−イルカルボン酸及びその製造方法
JP2008179562A (ja) Lxrアゴニスト
CS223890B2 (en) Method of making the derivatives of the 2,4,6-triiode-3-carbamoylbenzoo c-substuituted in the position 5 acid
UA80605C2 (en) The indazoles having an analgesic activity
JP5648693B2 (ja) サンショール類の製造方法
CN104892640B (zh) 2‑苯基‑6‑苯甲酰基‑噻唑并[3,2‑b][1,2,4]‑三氮唑类衍生物及应用
JP2022519974A (ja) Fxr作動薬の固体形態、結晶形態、結晶体a、その調製方法および応用
RU2778124C2 (ru) Способ приготовления полиморфной формы b диэтаноламиновой соли трепростинила
CN103958484A (zh) 噁唑烷酮类衍生物、其制备方法及其在医药上的应用
JP3773064B2 (ja) フェノキシアルキルカルボン酸誘導体の製造法